Without pre-dosing, a significantly higher accumulation in the PSMA+ tumor was observed based on the PET data for the control, as indicated by the PSMA+/PSMA− ratio of 2.57 ± 0.60 (Figure 3). Here, FOLH1 is linked to neoplasm.